--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About TNYA20260717C1
Biological Technology
Tenaya Therapeutics, Inc., was incorporated in Delaware in August 2016. The company is a preclinical stage biotechnology company focused on discovering, developing and delivering treatments for the underlying drivers of heart disease. The company is advancing product candidates from three distinct but interrelated product platforms: gene therapy, cell regeneration and precision medicine.
